Insider Trading History of Fraser Craig


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Fraser Craig since year 2005. The trader's CIK number is 1557420. At the time of the last reporting, Fraser Craig was the President and CEO of Windtree Therapeutics Inc /de/ . (stock ticker symbol WINT). See this page for all insider trading activities at Windtree Therapeutics Inc /de/ .

Note that in the past Fraser Craig also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Fraser Craig since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2020-02-10 WINT Windtree Therapeutics Inc /de/ Buy 250 4.10 1,025
2020-02-11 WINT Windtree Therapeutics Inc /de/ Buy 250 4.10 1,025
2020-02-03 WINT Windtree Therapeutics Inc /de/ Buy 100 4.20 420
2020-02-04 WINT Windtree Therapeutics Inc /de/ Buy 500 4.24 2,120
2016-10-28 WINT Windtree Therapeutics Inc /de/ Buy 7,500 2.05 15,382
2014-04-30 AEGR Aegerion Pharmaceuticals, Inc. Sale 2,250 43.54 97,965
2014-04-30 AEGR Aegerion Pharmaceuticals, Inc. Option Ex 2,250 13.01 29,272
2014-03-31 AEGR Aegerion Pharmaceuticals, Inc. Option Ex 2,250 13.01 29,272
2014-03-31 AEGR Aegerion Pharmaceuticals, Inc. Sale 2,250 46.52 104,663
2014-02-11 AEGR Aegerion Pharmaceuticals, Inc. Option Ex 2,250 13.01 29,272
2014-02-11 AEGR Aegerion Pharmaceuticals, Inc. Sale 2,250 67.00 150,750
2014-01-02 AEGR Aegerion Pharmaceuticals, Inc. Option Ex 2,250 13.01 29,272
2014-01-02 AEGR Aegerion Pharmaceuticals, Inc. Sale 2,250 71.03 159,826
2013-12-02 AEGR Aegerion Pharmaceuticals, Inc. Option Ex 2,250 13.01 29,272
2013-12-02 AEGR Aegerion Pharmaceuticals, Inc. Sale 2,250 70.60 158,847
2013-11-01 AEGR Aegerion Pharmaceuticals, Inc. Option Ex 2,250 13.01 29,272
2013-11-01 AEGR Aegerion Pharmaceuticals, Inc. Sale 2,250 83.17 187,121
2013-10-07 AEGR Aegerion Pharmaceuticals, Inc. Option Ex 20,000 13.01 260,200
2013-10-07 AEGR Aegerion Pharmaceuticals, Inc. Sale 20,000 94.16 1,883,280

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Fraser Craig (President and CEO of Windtree Therapeutics Inc /de/ at the time of this reporting) see the Securities and Exchange Commission (SEC) website.




Real-time Insider Trading

Insider Officer Cluster Trading

Top Officer Buys of the Week

Top Officer Buys of the Month